Coya Therapeutics (COYA) Institutional Ownership $6.41 +0.24 (+3.89%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$6.39 -0.02 (-0.30%) As of 02/21/2025 05:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Coya Therapeutics (NASDAQ:COYA)CurrentInstitutional OwnershipPercentage39.75%Number ofInstitutional Buyers(last 12 months)13TotalInstitutional Inflows(last 12 months)$13.82MNumber ofInstitutional Sellers(last 12 months)0 Get COYA Insider Trade Alerts Want to know when executives and insiders are buying or selling Coya Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data COYA Institutional Buying and Selling by Quarter Coya Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 DME Capital Management LP1,646,440$9.43M0.5%+29.2%9.853% 2/14/2025 Jane Street Group LLC12,961$74K0.0%N/A0.078% 2/14/2025 Northern Trust Corp28,549$164K0.0%+12.2%0.171% 2/14/2025 Tower Research Capital LLC TRC 5,252$30K0.0%+1,005.7%0.031% 2/13/2025 XTX Topco Ltd10,299$59K0.0%N/A0.062% 2/12/2025 Geode Capital Management LLC150,576$863K0.0%+5.8%0.901% 2/12/2025 AIGH Capital Management LLC1,201,152$6.88M2.2%+85.0%7.188% 2/7/2025 CM Management LLC160,000$917K0.8%+11.1%0.958% 1/28/2025 Newbridge Financial Services Group Inc.70,000$401K0.1%N/A0.419% 11/16/2024 Geode Capital Management LLC142,309$918K0.0%+3.3%0.852% 10/24/2024 GHP Investment Advisors Inc.26,171$169K0.0%N/A0.179% 8/9/2024 Renaissance Technologies LLC16,700$101K0.0%N/A0.114% 8/1/2024 Gilbert & Cook Inc.10,000$61K0.0%N/A0.068% 5/10/2024 Vanguard Group Inc.847,490$8.41M0.0%+772.3%5.804% 2/15/2024Greenlight Capital Inc.1,274,026$9.44M0.5%+172.2%12.702% 2/12/2024 AIGH Capital Management LLC1,031,977$7.38M2.9%+92.6%10.289% 2/9/2024 Worth Venture Partners LLC92,667$687K0.4%-30.8%0.924% 11/15/2023 Worth Venture Partners LLC134,006$519K0.3%-8.5%1.336% 11/13/2023 AIGH Capital Management LLC535,794$2.06M1.0%-8.7%5.342% 11/7/2023 CM Management LLC100,000$384K0.4%+66.7%1.005% 8/14/2023 Mirador Capital Partners LP15,361$63K0.0%N/A0.154% 8/4/2023 CM Management LLC60,000$244K0.2%N/A0.603% 2/16/2023 AIGH Capital Management LLC560,000$2.65M0.9%N/A5.785% (Data available from 1/1/2016 forward) COYA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of COYA shares? During the previous two years, 16 institutional investors and hedge funds held shares of Coya Therapeutics. The most heavily invested institutionals were Greenlight Capital Inc. ($9.44M), DME Capital Management LP ($9.43M), Vanguard Group Inc. ($8.41M), AIGH Capital Management LLC ($6.88M), CM Management LLC ($917K), Geode Capital Management LLC ($863K), and Worth Venture Partners LLC ($687K).Learn more on COYA's institutional investors. What percentage of Coya Therapeutics stock is owned by institutional investors? 39.75% of Coya Therapeutics stock is owned by institutional investors. Learn more on COYA's institutional investor holdings. Which institutional investors have been buying Coya Therapeutics stock? Of the 15 institutional investors that purchased Coya Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AIGH Capital Management LLC ($1.05M), Greenlight Capital Inc. ($805.96K), Vanguard Group Inc. ($750.34K), DME Capital Management LP ($372.41K), CM Management LLC ($115.94K), Newbridge Financial Services Group Inc. ($70K), and GHP Investment Advisors Inc. ($26.17K). How much institutional buying is happening at Coya Therapeutics? Institutional investors have bought a total of 3,274,680 shares in the last 24 months. This purchase volume represents approximately $23.93M in transactions. Which Coya Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Coya Therapeutics stock in the last 24 months: Worth Venture Partners LLC ($53.83K), and AIGH Capital Management LLC ($51.08K). How much institutional selling is happening at Coya Therapeutics? Institutional investors have sold a total of 104,904 shares in the last 24 months. This volume of shares sold represents approximately $550.41K in transactions. Related Companies Akebia Therapeutics Institutional Ownership KalVista Pharmaceuticals Institutional Ownership Sage Therapeutics Institutional Ownership PureTech Health Institutional Ownership Arcturus Therapeutics Institutional Ownership Organogenesis Institutional Ownership SIGA Technologies Institutional Ownership ChromaDex Institutional Ownership Keros Therapeutics Institutional Ownership ABIVAX Société Anonyme Institutional Ownership This page (NASDAQ:COYA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coya Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coya Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
